Publications by authors named "P Fodor"

Hematological and oncological diseases are still among the leading causes of childhood mortality. Expression of growth hormone-releasing hormone (GHRH) and its receptors (GHRH-R) has been previously demonstrated in various human tumors, but very limited findings are available about the presence and potential function of GHRH-Rs in oncological and hematological disorders of children. In this study, we aimed to investigate the expression of mRNA for GHRH and splice variant 1 (SV) of GHRH-R in 15 pediatric hematological/oncological specimens by RT-PCR.

View Article and Find Full Text PDF

Background: MicroRNAs (miRNAs) play a regulatory role in various human cancers. The roles of hsa-miR-15a-5p, hsa-miR-99b-5p, and hsa-miR-181a-5p have not been fully explored in the angiogenesis of renal cell carcinoma (RCC).

Aims: The present study aimed to evaluate the expression of these miRNAs in tumorous and adjacent healthy tissues of RCC.

View Article and Find Full Text PDF

Treatment of pelvic injuries poses serious problems for surgeons due to the difficulties of the associated injuries. The objective of this research is to create a clinical workflow that integrates three-dimensional technologies in preoperative planning and performing surgery for the reduction and stabilization of associated acetabular fractures. : The research methodology consisted of integrating the stages of virtual preoperative planning, physical preoperative planning, and performing the surgical intervention in a newly developed clinical workflow.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated whether volatile sedation with sevoflurane could protect organs in patients with severe COVID-19 lung injury experiencing a cytokine storm, particularly focusing on IL-6 levels.
  • Conducted as a pilot trial in Switzerland, 60 patients requiring mechanical ventilation were randomly assigned to receive either sevoflurane or continuous intravenous sedation, with their outcomes analyzed at 28 days.
  • Results showed no significant difference in primary outcomes such as mortality or persistent organ dysfunction between the two groups, but the sevoflurane group required fewer vasopressors and had higher reported acute kidney injury rates compared to controls.
View Article and Find Full Text PDF